EIT Health, in partnership with Abbott, has launched the third in a series of challenges and is actively seeking innovative, minimally or non-invasive solutions to assess immune status and function in healthy individuals by identifying and quantifying immune biomarkers. Approaches may include digital biomarkers, wearables, AI analytics, novel immune indicators, or non-invasive sampling. Methods must deliver quantitative, interpretable, clinically relevant insights, be cost-effective, and enable rapid, user-friendly deployment at the point of care, especially within clinical trials.
We are looking for solutions that:
- Use minimally invasive methods requiring no blood draws, with samples such as blood spots, breath, saliva, stool, urine, skin swabs, sweat, interstitial fluid, nasal swabs, or data from wearable sensors.
- Eliminate the need for extended cold storage by enabling analysis at the time of sampling or allowing sample storage at room temperature.
- Provide clinically meaningful measures that are linked to immune health and influenced by nutrition, supported by existing scientific literature.
- Offer low-cost implementation comparable to or lower than current clinical sampling and analysis methods.
Solutions should either (1) generate data compatible with existing clinical analysis infrastructure or (2) include integrated, proprietary analysis technologies tailored to the proposed method. The approach must deliver quantitative, interpretable, and clinically relevant insights into immune function, be cost-effective, and support rapid, user-friendly deployment at the point of care, particularly within the operational framework of clinical trials.
For more detailed information on the challenge, please read the document here.
